Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients

Ruize Gao

doi:10.21037/tcr-22-2173

Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients

Ruize Gao^*

^*Corresponding author for this work

Tumor Immunotherapy and Microenvironment

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Original language	English
Pages (from-to)	3932-3934
Number of pages	3
Journal	Translational Cancer Research
Volume	11
Issue number	11
DOIs	https://doi.org/10.21037/tcr-22-2173
Publication status	Published - Nov 2022

Access to Document

10.21037/tcr-22-2173Licence: CC BY-NC-ND

Cite this

@article{c11bc96781204ff0a5091dffd4dd0708,

title = "Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients",

author = "Ruize Gao",

note = "Funding: None",

year = "2022",

month = nov,

doi = "10.21037/tcr-22-2173",

language = "English",

volume = "11",

pages = "3932--3934",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

number = "11",

}

TY - JOUR

T1 - Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients

AU - Gao, Ruize

N1 - Funding: None

PY - 2022/11

Y1 - 2022/11

UR - https://www.scopus.com/pages/publications/85147650816

UR - https://pubmed.ncbi.nlm.nih.gov/36523316

U2 - 10.21037/tcr-22-2173

DO - 10.21037/tcr-22-2173

M3 - Editorial

C2 - 36523316

SN - 2218-676X

VL - 11

SP - 3932

EP - 3934

JO - Translational Cancer Research

JF - Translational Cancer Research

IS - 11

ER -

Hypoxia features as potential indicators in prognosis, immunotherapy and drug screening in hepatocellular carcinoma patients

Access to Document

Other files and links

Cite this